Advancing science across hematology. 馃敩 At #ASH2026, we'll share a breadth of data spanning our broad malignant and classical hematology programs. Explore our expanding research: bit.ly/4AeBMap
Regeneron
This account is verified because it's an official organization on X. Learn more@Regeneron
Official channel for Regeneron. We turn science into medicine for people with serious diseases. View our terms of engagement here: ow.ly/UMYS30iRqZ4
254 Following 34K Followers 5.2K Posts
Latest posts 5
The U.S. FDA has approved our medicine as the first and only siRNA therapy in generalized myasthenia gravis (#gMG), which offers a new approach for people living with this debilitating, often unpredictable disease.
聽
Read more: bit.ly/491nvl7
聽
Read more: bit.ly/491nvl7
0:12
We are pleased to share that the European Commission (EC) has approved an updated dosing regimen for our medicine across its currently approved indications in skin, lung, and cervical cancers. Learn more: bit.ly/3Wy6I6x
0:10
Today we presented results from our POTS (postural orthostatic tachycardia syndrome) Phase 2 trial at the American Autonomic Society annual meeting.
聽
Read the release to learn more about our novel investigational therapy: bit.ly/4kUeuBs
聽
#AAS2026 #POTS
聽
Read the release to learn more about our novel investigational therapy: bit.ly/4kUeuBs
聽
#AAS2026 #POTS
We presented positive results for our investigational siRNA therapeutic in metabolic dysfunction-associated steatotic liver disease (#MASLD) at #AASLD2026 that were also published by @NEJM.
Learn more: bit.ly/4ixUodu
Learn more: bit.ly/4ixUodu